Recent Advances in Cyclin-Dependent Kinase Inhibition. Purine-Based Derivatives as Anti-Cancer Agents. Roles and Perspectives for the Future

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|2|9|1037-1050

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.2, Iss.9, 2002-09, pp. : 1037-1050

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclin-dependent kinase inhibitors: novel anticancer agents

By Mani S.   Wang C.   Wu K.   Francis R.   Pestell R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1849-1870

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents

By  

Current Medicinal Chemistry, Vol. 22, Iss. 2, 2014-12 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Research in Selective Cyclin-Dependent Kinase 4 Inhibitors for Anti-Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 16, Iss. 36, 2009-12 ,pp. : 4869-4888

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-Dependent Kinase Inhibition by Flavoalkaloids

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 7, 2012-06 ,pp. : 632-649

Bentham Science Publishers

Access to resources Recommend Favorite

Flavopiridol, the First Cyclin-Dependent Kinase Inhibitor: Recent Advances in Combination Chemotherapy

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 11, 2010-10 ,pp. : 1058-1070

Bentham Science Publishers

Access to resources Recommend Favorite